Stem cell therapy for the treatment of Peyronie’s disease

References

• Hatzimouratidis K, Eardley I, Giuliano F, et al. EAU guidelines on penile curvature. Eur Urol. 2012;62:543–552.
   PubMed Web of Science ®Google Scholar
• Sommer F, Schwarzer U, Wassmer G, et al. Epidemiology of Peyronie’s disease. Int J Impot Res. 2002;14:379–383.
   PubMed Web of Science ®Google Scholar
• Arafa M, Eid H, El-Badry A, et al. The prevalence of Peyronie’s disease in diabetic patients with erectile dysfunction. Int J Impot Res. 2007;19(2):213–217.
   PubMed Web of Science ®Google Scholar
• Dunsmuir WD, Kirby R. Francois de LaPeyronie (1978–1747): the man and the disease he described. Br J Urol. 1996;78:613–622.
   PubMedGoogle Scholar
• Konstantinidis K, Kuehhas F, Papatsoris A. The Egydio geometrical procedure for managing penile curvature using a single relaxing incision: a single-centre experience with 330 patients. Arab J Urol. 2015;13:287–290.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Cadavid NF, Raifer J. Experimental models of Peyronie’s disease. Implications for new therapies. J Sex Med. 2009;6:303–313.
   PubMed Web of Science ®Google Scholar
• Lander EB, Berman MH, See JR. Stromal vascular fraction combined with shock wave for the treatment of Peyronie’s disease. PRS Globe Open. 2016;4:e631.
   Google Scholar
• Jackson WM, Nesti LJ, Tuan RS. Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther. 2012;3:20.
   PubMed Web of Science ®Google Scholar
• Musitelli S, Bossi M, Jallous H. A brief historical survey of ‘Peyronie’s disease.’ J Sex Med. 2008;5:37–46.
   Web of Science ®Google Scholar
• Nelson CJ, Diblasio C, Kendirci M, et al. The chronology of depression and distress in men with Peyronie’s disease. J Sex Med. 2008;5:1985–1990.
   PubMed Web of Science ®Google Scholar
• Devine CJ Jr, Somers KD, Jordan SG, et al. Proposal: trauma as the cause of the Peyronie’s lesion. J Urol. 1997;157:285–290.
   PubMed Web of Science ®Google Scholar
• Ehrlich HP. Scar contracture: cellular and connective tissue aspects in Peyronie’s disease. J Urol. 1997;157:316–319.
   PubMed Web of Science ®Google Scholar
• Somers KD, Dawson DM. Fibrin deposition in Peyronie’s disease plaque. J Urol. 1997;157:311–315.
   PubMed Web of Science ®Google Scholar
• El-Sakka AI, Hassoba HM, Pillarisetty RJ, et al. Peyronie’s disease is associated with an increase in transforming growth factor-beta protein expression. J Urol. 1997;158:1391–1394.
   PubMed Web of Science ®Google Scholar
• El-Sakka AI, Hassoba HM, Chui RM, et al. An animal model of Peyronie’slike condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol. 1997;158:2284–2290.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Cadavid NF, Rajfer J. Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie’s disease. Nat Clin Pract Urol. 2005;2:291–297.
   PubMedGoogle Scholar
• Lue TF. Peyronie’s disease: an anatomically-based hypothesis and beyond. Int J Impot Res. 2002;14:411–413.
   PubMed Web of Science ®Google Scholar
• Davila HH, Ferrini MG, Rajfer J, et al. Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie’s disease. BJU Int. 2003;91(9):830–838.
   PubMed Web of Science ®Google Scholar
• Bivalacqua TJ, Diner E. A rat model of Peyronie disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol. 2000;163:1992–1998.
   PubMed Web of Science ®Google Scholar
• Ferrini MG, Vernet D-C. Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide. 2002;6:283–294.
   PubMed Web of Science ®Google Scholar
• Soebadi MA, Moris L, Castiglione F, et al. Advances in stem cell research for the treatment of male sexual dysfunctions. Curr Opin Urol. 2016;26(2):129–139.
   PubMed Web of Science ®Google Scholar
• Hassoba H, El-Sakka A, Lue T. Role of increased transforming growth factor beta protein expression in the pathogenesis of Peyronie’s disease. Egypt J Immunol. 2005;12:1–8.
   PubMedGoogle Scholar
• Levine L, Rybak J, Corder C, et al. Peyronie’s disease plaque calcification – prevalence, time to identification, and development of a new grading classification. J Sex Med. 2013;10:3121–3128.
   PubMed Web of Science ®Google Scholar
• Jarow JP, Lowe F. Penile trauma: an etiologic factor in Peyronie disease and erectile dysfunction. J Urol. 1997;158:1388–1390.
   PubMed Web of Science ®Google Scholar
• Magee TR, Qian A, Rajfer J, et al. Gene expression profiles in the Peyronie’s disease plaque. Urology. 2002;59(3):451–457.
   PubMed Web of Science ®Google Scholar
• Vernet D, Ferrini MG, Valente EG, et al. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie’s fibrotic plaque and in its rat model. Nitric Oxide. 2002;7(4):262–276.
   PubMed Web of Science ®Google Scholar
• Gelfand R, Vernet R, Kovanecz I, et al. The transcriptional signatures of cells from the human Peyronie’s disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets. J Sex Med. 2015;12(2):313–327.
   PubMed Web of Science ®Google Scholar
• Ferretti L, Giuliani M, Bessede T, et al. Tissue engineering for penile surgery: comparative study of noncellular and cell-seeded synthetic grafts for tunica albuginea replacement. J Sex Med. 2012;9:625–631.
   PubMed Web of Science ®Google Scholar
• Imbeault A, Bernard G, Ouellet G, et al. Surgical option for the correction of Peyronie’s disease: an autologous tissue-engineered endothelialized graft. J Sex Med. 2011;8:3227–3235.
   PubMed Web of Science ®Google Scholar
• Castiglione F, Hedlund P, van der Aa F, et al. Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie’s disease. Eur Urol. 2013;63:551–560.
   PubMed Web of Science ®Google Scholar
• Kumai Y, Kobler JB, Park H, et al. Modulation of vocal fold scar fibroblasts by adipose-derived stem/stromal cells. Laryngoscope. 2010;120:330–337.
   PubMed Web of Science ®Google Scholar
• Tan RB, Sangkum P, Mitchell GC, et al. Update on medical management of Peyronie’s disease. Curr Urol Rep. 2014;15(6):415–423.
   PubMed Web of Science ®Google Scholar
• Gokce A, Abd Elmageed ZY, Lasker GF, et al. Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie’s disease. Andrology. 2014;2:244–251.
   PubMed Web of Science ®Google Scholar
• Gokce A, Abd Elmageed ZY, Lasker GF, et al. Intratunical injection of genetically modified adipose tissue-derived stem cells with human interferon a-2b for treatment of erectile dysfunction in a rat model of tunica albugineal fibrosis. J Sexual Med. 2015;12:1533–1544.
   PubMed Web of Science ®Google Scholar
• da Silva Meirelles L, Chagastelle PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(11):2204–2213.
   PubMed Web of Science ®Google Scholar
• Lin CS, Lue TF. Adipose-derived stem cells: therapy through paracrine actions. In: Hayat MA, ed. Stem cells and cancer stem cells. Vol. 4. New York, NY: Springer; 2012. p. 203–216.
   Google Scholar
• Crisan M, Yap S, Catseilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3(3):301–313.
   PubMed Web of Science ®Google Scholar
• Lin G, Garcia M, Ning H, et al. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008;17:1053–1063.
   PubMed Web of Science ®Google Scholar
• Albersen M, Kendirci M, van der Aa F, et al. Multipotent stromal cell therapy for cavernous nerve injury induced erectile dysfunction. J Sex Med. 2012;9:385–403.
   PubMed Web of Science ®Google Scholar
• Alwaal A, Hussein AA, Lin C-S, et al. Prospects of stem cell treatment in benign urological diseases. Korean J Urol. 2015;56:257–265.
   PubMedGoogle Scholar
• Ning H, Lin G, Lue TF, et al. Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation. 2006;74:510–518.
   PubMed Web of Science ®Google Scholar
• Ning H, Liu G, Lin G, et al. Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med. 2009;6:967–979.
   PubMed Web of Science ®Google Scholar
• Chamberlain G, Fox J, Ashton B, et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25:2739–2749.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ning H, Banie L, et al. Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties. Biochem Biophys Res Commun. 2010;402:560–564.
   PubMed Web of Science ®Google Scholar
• Ma L, Yang Y, Sikka SC, et al. Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction. Proc Natl Acad Sci USA. 2012;109(6):2090–2095.
   PubMed Web of Science ®Google Scholar
• Gokce A, Peak TC, Abdel-Mageed AB, et al. Adipose tissue-derived stem cells for the treatment of erectile dysfunction. Curr Urol Rep. 2016;17(2):14.
   PubMed Web of Science ®Google Scholar
• Liu G, Sun X, Bian J, et al. Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model. Plos One. 2013;8(8):e72790.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim IG, Jung AR, et al. Combined effects of brain-derived neurotrophic factor immobilized poly-lactic-co-glycolic acid membrane with human adiposederived stem cells and basic fibroblast growth factor hydrogel on recovery of erectile dysfunction. Tissue Eng Part A. 2014;20(17–18):2446–2454.
   PubMed Web of Science ®Google Scholar
• Marchand M Evaluate the safety and feasibility of injecting placental matrix-derived mesenchymal stem cells into the penis to treat the symptoms of Peyronie’s disease. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 -[cited 2016 Nov 20]. Available from: https://clinicaltrials.gov/ct2/show/study/NCT02395029. NLM Identifier: NCT02395029.
   Google Scholar
• Levy JA, Marchand M, Iorio L, et al. Effects of stem cell treatment in human patients with Peyronie disease. J Am Osteopath Assoc. 2015;115(10):e8–13.
   PubMed Web of Science ®Google Scholar
• Man Clinic for Andrology, Male Infertility and Sexual Dysfunction; Cairo, Egypt. The role of adipose tissue stem cell injection through corpora cavernosa and intra dorsal penile artery in management of erectile dysfunction associated with Peyronie’s disease. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 – [cited 2016 Nov 20]. Available from: https://clinicaltrials.gov/ct2/show/study/NCT02414308. NLM Identifier: NCT02414308.
   Google Scholar